Susunod

Auto-play

Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas

14 Mga view • 07/18/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play